A citation-based method for searching scientific literature

Manuela Tosi, Orietta Spinelli, Matteo Leoncin, Roberta Cavagna, Chiara Pavoni, Federico Lussana, Tamara Intermesoli, Luca Frison, Giulia Perali, Francesca Carobolante, Piera Viero, Cristina Skert, Alessandro Rambaldi, Renato Bassan. Cancers (Basel) 2021
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.
Wendy Stock, Selina M Luger, Anjali S Advani, Jun Yin, Richard C Harvey, Charles G Mullighan, Cheryl L Willman, Noreen Fulton, Kristina M Laumann, Greg Malnassy,[...]. Blood 2019
190
100

Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
Helen M Parsons, Linda C Harlan, Nita L Seibel, Jennifer L Stevens, Theresa H M Keegan. J Clin Oncol 2011
128
50

Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
Stuart E Siegel, Wendy Stock, Rebecca H Johnson, Anjali Advani, Lori Muffly, Dan Douer, Damon Reed, Mark Lewis, David R Freyer, Bijal Shah,[...]. JAMA Oncol 2018
71
50

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Sabina Chiaretti, Monica Messina, Irene Della Starza, Alfonso Piciocchi, Luciana Cafforio, Marzia Cavalli, Akram Taherinasab, Michela Ansuinelli, Loredana Elia, Guglielmo Albertini Petroni,[...]. Haematologica 2021
26
50

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07.
Renato Bassan, Chiara Pavoni, Tamara Intermesoli, Orietta Spinelli, Manuela Tosi, Ernesta Audisio, Filippo Marmont, Chiara Cattaneo, Erika Borlenghi, Sergio Cortelazzo,[...]. Blood Cancer J 2020
15
50


Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.
Sébastien Maury, Sylvie Chevret, Xavier Thomas, Dominik Heim, Thibaut Leguay, Françoise Huguet, Patrice Chevallier, Mathilde Hunault, Nicolas Boissel, Martine Escoffre-Barbe,[...]. N Engl J Med 2016
188
50

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
50

Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
Michael E Rytting, Elias J Jabbour, Jeffrey L Jorgensen, Farhad Ravandi, Anna R Franklin, Tapan M Kadia, Naveen Pemmaraju, Naval G Daver, Alessandra Ferrajoli, Guillermo Garcia-Manero,[...]. Am J Hematol 2016
81
50


Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
Hagop Kantarjian, Anthony Stein, Nicola Gökbuget, Adele K Fielding, Andre C Schuh, Josep-Maria Ribera, Andrew Wei, Hervé Dombret, Robin Foà, Renato Bassan,[...]. N Engl J Med 2017
983
50

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Patrick A Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura E Hogan, Michael J Borowitz, Elizabeth A Raetz, Gerhard Zugmaier, Elad Sharon, Melanie B Bernhardt,[...]. JAMA 2021
75
50

Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.
Lori Muffly, Elysia Alvarez, Daphne Lichtensztajn, Renata Abrahão, Scarlett Lin Gomez, Theresa Keegan. Blood Adv 2018
38
50

Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.
Donald A Berry, Shouhao Zhou, Howard Higley, Lata Mukundan, Shuangshuang Fu, Gregory H Reaman, Brent L Wood, Gary J Kelloff, J Milburn Jessup, Jerald P Radich. JAMA Oncol 2017
244
50

Acute Lymphoblastic Leukemia in Children.
Stephen P Hunger, Charles G Mullighan. N Engl J Med 2015
936
50

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
Partow Kebriaei, Corey Cutler, Marcos de Lima, Sergio Giralt, Stephanie J Lee, David Marks, Akil Merchant, Wendy Stock, Koen van Besien, Matthias Stelljes. Bone Marrow Transplant 2018
61
50

Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic.
Charles G Mullighan, Cheryl L Willman. J Adolesc Young Adult Oncol 2011
14
50

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232.
Eric C Larsen, Meenakshi Devidas, Si Chen, Wanda L Salzer, Elizabeth A Raetz, Mignon L Loh, Leonard A Mattano, Catherine Cole, Alisa Eicher, Maureen Haugan,[...]. J Clin Oncol 2016
210
50

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol.
Akhil Rajendra, Hasmukh Jain, V N Avinash Bonda, Lingaraj Nayak, Prashant Tembhare, Dhanlaxmi Shetty, Jayashree Thorat, Hemani Jain, Papagudi Ganesan Subramanian, Nikhil Patkar,[...]. Blood Adv 2021
8
50

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.
Françoise Huguet, Sylvie Chevret, Thibaut Leguay, Xavier Thomas, Nicolas Boissel, Martine Escoffre-Barbe, Patrice Chevallier, Mathilde Hunault, Norbert Vey, Caroline Bonmati,[...]. J Clin Oncol 2018
65
50

Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.
Merav Bar, Brent L Wood, Jerald P Radich, Kristine C Doney, Ann E Woolfrey, Colleen Delaney, Frederick R Appelbaum, Ted A Gooley. Leuk Res Treatment 2014
59
50


Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER database.
Elisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, Ibrahim Aldoss, Vinod Pullarkat, Eduardo Rego, Guido Marcucci, Dan Douer. Hematol Oncol 2022
1
100

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
Kathryn G Roberts, Yongjin Li, Debbie Payne-Turner, Richard C Harvey, Yung-Li Yang, Deqing Pei, Kelly McCastlain, Li Ding, Charles Lu, Guangchun Song,[...]. N Engl J Med 2014
856
50

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.
Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, Claus-Rainer Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolf-Dieter Ludwig,[...]. Blood 2012
303
50

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.
D J DeAngelo, K E Stevenson, S E Dahlberg, L B Silverman, S Couban, J G Supko, P C Amrein, K K Ballen, M D Seftel, A R Turner,[...]. Leukemia 2015
199
50

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia.
Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Christoph Faul, Helmut Diedrich, Max S Topp, Monika Brüggemann, Heinz-August Horst,[...]. Blood 2018
382
50

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
Hagop M Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Giovanni Martinelli, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O'Brien, Kongming Wang, Tao Wang,[...]. N Engl J Med 2016
720
50

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.
N Toft, H Birgens, J Abrahamsson, L Griškevičius, H Hallböök, M Heyman, T W Klausen, Ó G Jónsson, K Palk, K Pruunsild,[...]. Leukemia 2018
214
50

Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Matthew D Seftel, Donna Neuberg, Mei-Jie Zhang, Hai-Lin Wang, Karen Kuhn Ballen, Julie Bergeron, Stephen Couban, César O Freytes, Mehdi Hamadani, Mohamed A Kharfan-Dabaja,[...]. Am J Hematol 2016
55
50


An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL.
Matthew Greenwood, Toby Trahair, Rosemary Sutton, Michael Osborn, John Kwan, Sally Mapp, Rebecca Howman, Antoinette Anazodo, Brenton Wylie, James D'Rozario,[...]. Blood Adv 2021
2
50

Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.
Kelly W Maloney, Meenakshi Devidas, Cindy Wang, Leonard A Mattano, Alison M Friedmann, Patrick Buckley, Michael J Borowitz, Andrew J Carroll, Julie M Gastier-Foster, Nyla A Heerema,[...]. J Clin Oncol 2020
59
50

Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis.
Zhenglei Shen, Xuezhong Gu, Wenwen Mao, Liefen Yin, Ling Yang, Zhe Zhang, Kunmei Liu, Lilan Wang, Yunchao Huang. BMC Cancer 2018
32
50


A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Josep-Maria Ribera, Mireia Morgades, Pau Montesinos, Mar Tormo, Daniel Martínez-Carballeira, José González-Campos, Cristina Gil, Pere Barba, Raimundo García-Boyero, Rosa Coll,[...]. Cancer Med 2020
9
50

Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop.
Sharyl J Nass, Lynda K Beaupin, Wendy Demark-Wahnefried, Karen Fasciano, Patricia A Ganz, Brandon Hayes-Lattin, Melissa M Hudson, Brenda Nevidjon, Kevin C Oeffinger, Ruth Rechis,[...]. Oncologist 2015
163
50

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
Tobias Herold, Stephanie Schneider, Klaus H Metzeler, Martin Neumann, Luise Hartmann, Kathryn G Roberts, Nikola P Konstandin, Philipp A Greif, Kathrin Bräundl, Bianka Ksienzyk,[...]. Haematologica 2017
90
50

Adherence to Oral Medications During Maintenance Therapy Among Children and Adolescents With Acute Lymphoblastic Leukemia: A Medication Refill Analysis.
Yelena P Wu, David D Stenehjem, Lauri A Linder, Bin Yu, Bridget Grahmann Parsons, Ryan Mooney, Mark N Fluchel. J Pediatr Oncol Nurs 2018
7
50

Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
Anna Maria Testi, Martina Canichella, Antonella Vitale, Alfonso Piciocchi, Anna Guarini, Irene Della Starza, Marzia Cavalli, Maria Stefania De Propris, Monica Messina, Loredana Elia,[...]. Am J Hematol 2021
13
50

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia.
Nicola Gökbuget, Gerhard Zugmaier, Hervé Dombret, Anthony Stein, Massimiliano Bonifacio, Carlos Graux, Christoph Faul, Monika Brüggemann, Kate Taylor, Noemi Mergen,[...]. Leuk Lymphoma 2020
17
50

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.
Nathalie Dhédin, Anne Huynh, Sébastien Maury, Reza Tabrizi, Kheira Beldjord, Vahid Asnafi, Xavier Thomas, Patrice Chevallier, Stéphanie Nguyen, Valérie Coiteux,[...]. Blood 2015
166
50

Advances in the Genetics and Therapy of Acute Lymphoblastic Leukemia.
Sabina Chiaretti, Valentina Gianfelici, Susan M O'Brien, Charles G Mullighan. Am Soc Clin Oncol Educ Book 2016
25
50

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
Jiří Pavlů, Myriam Labopin, Riitta Niittyvuopio, Gerard Socié, Ibrahim Yakoub-Agha, Depei Wu, Peter Remenyi, Jakob Passweg, Dietrich W Beelen, Mahmoud Aljurf,[...]. J Hematol Oncol 2019
33
50

Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States.
Helen M Parsons, Dolly C Penn, Qian Li, Rosemary D Cress, Brad H Pollock, Marcio H Malogolowkin, Ted Wun, Theresa H M Keegan. Pediatr Blood Cancer 2019
31
50

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
Anjali S Advani, Eric Larsen, Kristina Laumann, Selina M Luger, Michaela Liedtke, Meenakshi Devidas, Zhiguo Chen, Jun Yin, Matthew C Foster, David Claxton,[...]. Blood Adv 2021
9
50

Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia.
R Bassan, O Spinelli, E Oldani, T Intermesoli, M Tosi, B Peruta, E Borlenghi, E M Pogliani, E Di Bona, V Cassibba,[...]. Blood Cancer J 2014
45
50

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
Nitin Jain, Kathryn G Roberts, Elias Jabbour, Keyur Patel, Agda Karina Eterovic, Ken Chen, Patrick Zweidler-McKay, Xinyan Lu, Gloria Fawcett, Sa A Wang,[...]. Blood 2017
193
50

Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.
Elias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, Xavier Thomas, Richard A Larson, Sung-Soo Yoon, Armin Ghobadi, Max S Topp, Qui Tran, Janet L Franklin,[...]. Cancer 2019
41
50

The genetics and molecular biology of T-ALL.
Tiziana Girardi, Carmen Vicente, Jan Cools, Kim De Keersmaecker. Blood 2017
166
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.